Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)

Naohiro Takeshita, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Akihisa Wada, Masanobu Sato, Hideki Tanaka, Nobukazu Tanaka, Ryutaro Onaga, Yuta Hoshi, Shingo Sakashita, Genichiro Ishii, Makoto Tahara

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Weekly paclitaxel, carboplatin and cetuximab (PCE) combination followed by nivolumab for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)'. Together they form a unique fingerprint.

Medicine & Life Sciences